Comparison between Aritas Vinyl IPO and GNH India Pharmaceuticals IPO.
IPO Details
Aritas Vinyl IPO is a SME Bookbuilding IPO proposed to list at BSE SME while GNH India Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Aritas Vinyl IPO is up to ₹35.63 Cr whereas the issue size of the GNH India Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Aritas Vinyl IPO is ₹47.00 per share and of GNH India Pharmaceuticals IPO is .
| | Aritas Vinyl IPO | GNH India Pharmaceuticals IPO |
|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹40.00 per share | |
| Issue Price (Upper) | ₹47.00 per share | |
| Issue Price (Final) | ₹47.00 per share | |
| Discount (Retail) | | |
| Discount (Employee) | | |
| Market Lot Size | 3000 shares | |
| Fresh Issue Size | 65,96,600 shares | 37,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹31.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 9,84,400 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹4.63 Cr | up to ₹0.00 Cr |
| Issue Size Total | 75,81,000 shares | 37,00,000 shares |
| Issue Size Total (Amount) | up to ₹35.63 Cr | up to ₹0.00 Cr |
IPO Timetable
Aritas Vinyl IPO opens on Jan 16, 2026, while GNH India Pharmaceuticals IPO opens on . The closing date of Aritas Vinyl IPO and GNH India Pharmaceuticals IPO is Jan 20, 2026, and , respectively.
Financials & KPIs
Aritas Vinyl IPO P/E ratio is 14.43, as compared to GNH India Pharmaceuticals IPO P/E ratio of .
Shares Offered
In the Aritas Vinyl IPO Retail Individual Investors (RII) are offered 45,12,000 shares while in GNH India Pharmaceuticals IPO retail investors are offered 45,12,000 shares. Qualified Institutional Buyers (QIB) are offered 78,000 shares in Aritas Vinyl IPO and 0 shares in GNH India Pharmaceuticals IPO.
Bids Received (Subscription)
Aritas Vinyl IPO subscribed 2.21x in total, whereas GNH India Pharmaceuticals IPO subscribed .
